相关实验视频
Updated: Jan 18, 2026

07:15
An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
3.0K
一个案例系列:接受索塔切尔cept治疗的患者的心周溢血
Ariel M McKenna1, Nicholas S Hill1, Harrison W Farber1
1Division of Pulmonary, Critical Care, and Sleep Medicine Tufts Medical Center Boston Massachusetts USA.
Pulmonary circulation
|September 9, 2025
概括
针对TGF-β信号的肺动脉高血压 (PAH) 疗法是有希望的. 研究人员调查了新型PAH药物索塔雷cept是否会引起心周溢血,这是用cibotercept观察到的副作用.
科学领域:
- 心血管医学 心血管医学
- 肺高血压研究 肺高血压研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺动脉高血压 (PAH) 涉及血管收缩,扩散和纤维化,导致右心室衰竭.
- 目前的PAH治疗侧重于内甲素,氧化和前环素通路.
- 转化生长因子-β (TGF-β) 途径失调与PAH有关,导致新的治疗策略.
研究的目的:
- 为了研究心周溢出在接受sotatercept治疗的患者的潜在副作用.
- 在与类似的TGF-β通路抑制剂出现的担忧的背景下,评估sotatercept的安全性.
- 评估sotatercept是否与cibotercept共享不良事件,特别是心周溢血.
主要方法:
- 对接受PAH治疗的患者进行了回顾性分析.
- 对不良事件的监测和记录,重点是心周溢出.
- 观察到的副作用与其他TGF-β通路药物的已知不良事件的比较.
主要成果:
- 在接受sotatercept治疗的患者中,心周溢出发生率的数据.
- 评估临床意义和管理任何观察到的溢出.
- 关于心血管不良事件的sotatercept安全性概况的评估.
结论:
- 索塔特塞普特的安全性需要持续评估,特别是在心血管方面的副作用,如心周溢血等方面.
- 了解潜在的不良事件对于针对TGF-β通路的新型PAH疗法的临床应用至关重要.
- 需要进一步的研究,以充分阐明sotatercept在治疗肺动脉高血压方面的风险和益处.
相关概念视频
Pericarditis III: Medical Management
316
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
316
Pericarditis II: Clinical Features and Diagnostic Tests
291
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
291
Pericarditis I: Introduction
338
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
338
Pericarditis IV: Nursing Management
324
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
324
Cardiomyopathy IV: Restrictive Cardiomyopathy
472
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
472
Myocarditis III: Medical Management
178
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
178

